GE Healthcare Completes Tender Offer for Clarient

The merger is expected to accelerate the development of integrated tools for cancer diagnosis and characterization.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories